Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence-Reference-Cited by-同舟云学术

Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence

Published:2022-01-18 Issue:2 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Fiorentino David F.,Mecoli Christopher A.,Rosen Matthew C.^ORCID,Chung Lorinda S.^ORCID,Christopher-Stine Lisa^ORCID,Rosen Antony,Casciola-Rosen Livia

Funder

National Institutes of Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/150201/files/pdf

Reference38 articles.

1. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study;Hill;Lancet,2001

2. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study;Sigurgeirsson;N Engl J Med,1992

3. Review: cancer-induced autoimmunity in the rheumatic diseases;Shah;Arthritis Rheumatol,2015

4. Use of anti-transcriptional intermediary factor-1 gamma autoantibody in identifying adult dermatomyositis patients with cancer: a systematic review and meta-analysis;Best;Acta Derm Venereol,2019

5. Anti-TIF1-gamma autoantibodies: warning lights of a tumour autoantigen;De Vooght;Rheumatology (Oxford),2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and laboratory features between anti‐TIF1γ dermatomyositis with and without malignancy: 37 case series and a review;The Journal of Dermatology;2024-09-11

2. SOX‐5 Transcription Factor: a Novel Psoriatic Autoantigen Preferentially Found in Women;ACR Open Rheumatology;2024-09

3. Innovation in Dermatomyositis;Dermatologic Clinics;2024-09

4. Autoantibody testing in myositis: an update;Current Opinion in Rheumatology;2024-08-20

5. Dermatomyositis, Antisynthetase-Syndrom und immunvermittelte nekrotisierende Myopathie;Aktuelle Rheumatologie;2024-06